In addition, strong support come from a study where everolimus combined with an aromatase inhibitor improved progression-free survival in patients with hormone-receptor–positive advanced breast cancer previously treated with nonsteroidal aromatase inhibitors [43]. The gene discussed is NR4A1; the disease is breast cancer.